Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]        
Collaboration revenue $ 742,558 $ 170,454 $ 1,535,754 $ 284,090
Operating expenses:        
Research and development 4,315,632 1,634,800 10,056,568 4,065,486
General and administrative 1,760,696 790,576 3,891,810 2,571,521
Total operating expenses 6,076,328 2,425,376 13,948,378 6,637,007
Operating loss (5,333,770) (2,254,922) (12,412,624) (6,352,917)
Other income (expense):        
Interest income, net 1,731 1,037 420 773
Foreign currency exchange loss (14,729) (16,196)
Other income (expense), net (12,998) 1,037 (15,776) 773
Net loss $ (5,346,768) $ (2,253,885) $ (12,428,400) $ (6,352,144)
Net loss per share, basic and diluted $ (0.12) $ (0.06) $ (0.31) $ (0.22)
Weighted average number of common shares outstanding, basic and diluted 43,783,504 34,770,597 40,059,364 29,242,236